Cross-border remittance risk management tips for Hongkongers
letters@scmp.com or filling in
this Google form . Submissions should not exceed 400 words, and must include your full name and address, plus a phone number for verification
I refer to 'Mainland China, Hong Kong launching Payment Connect scheme to facilitate capital flows' (
June 20 ).
Hong Kong residents can now transfer funds to the mainland quickly and at lower costs. However, beneath this convenience lies a new regulatory landscape that requires careful attention.
While many may assume that only capital outflows from the mainland are tightly controlled, inbound funds – including those from Hong Kong – are increasingly monitored with the same intensity.
Hong Kong residents should understand that all cross-border remittance data is now immediately accessible to the mainland authorities. AI-driven systems have been designed to detect abnormal financial patterns, trace fund sources and enforce supervision.
To mitigate regulatory risks, it is crucial to ensure that all remittances are legitimate, well-documented and clearly justified. Priority should be given to straightforward, low-risk transfers such as living expenses, family support, medical costs or tuition payments.
Consistency is key. Avoid frequent, small-value transfers that might resemble attempts to circumvent annual remittance limits. Large single transfers may be safer if fully within the regulatory limit and backed by transparent documentation.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
an hour ago
- South China Morning Post
Man, 80, talked into 67-month phone plan costing 6 times as much: Hong Kong watchdog
An elderly man was locked into a 67-month mobile phone plan costing six times his usual bill for unneeded services, according to Hong Kong's consumer watchdog, as it warned that elderly residents were among the vulnerable targets of those using predatory telecommunications sales tactics. The case was one of thousands of related complaints received by the Consumer Council over the past two years, with issues ranging from elderly customers being oversold services to unfair auto-renewal clauses and long refund delays. The victim of the phone plan case, the 80-year-old father of a complainant, had previously been paying less than HK$100 (US$12.74) per month for his mobile service. However, after a visit to a physical branch of 'Company A' in August 2024, he was persuaded to sign up for a 67-month contract with a monthly bill of about HK$600, including a basic fee of HK$478, an HK$18 'tunnel fee', and several redundant add-on services, according to the watchdog. The extras comprised a secondary SIM card, two data roaming pass packages, two voice and data roaming packages, and four cloud storage services that would cost an additional HK$60 per month after a three-month free trial, unless cancelled. Suspecting his father had been deliberately upsold by staff – especially since the elderly man neither needed a secondary SIM card nor roaming services as he did not travel – the son sought an unconditional contract termination or to switch to a more suitable plan.
South China Morning Post
an hour ago
- South China Morning Post
‘China's Ozempic' pioneer inks deal with JD Health for online distribution
Innovent Biologics, the first Chinese company to win regulatory approval to sell a GLP-1 drug for weight loss and diabetes, will leverage JD Health's online distribution network as it seeks to grab a slice of a market that could be worth 40 billion yuan (US$5.6 billion) in a decade. The companies will collaborate on supply chain and sales channel development ahead of Innovent's launch of mazdutide, as well as engage in a consumer education campaign. 'Innovent and JD Health will join hands to popularise knowledge about weight loss and blood sugar control via on and offline channels,' Innovent said in a statement posted on its WeChat account on Tuesday. Late last month, eastern Jiangsu province-based Innovent said it received Chinese regulatory approval for mazdutide, which it claimed was the world's first to mimic the natural hormones of GLP-1 and glucagon, with the latter playing a crucial role in regulating blood glucose levels. GLP-1 drugs mimic the actions of the naturally produced hormone glucagon-like peptide-1, which regulates blood sugar levels, suppresses appetite and slows digestion. A woman injects insulin with an insulin pen to treat her diabetes at home. Photo: Shutterstock Images 'Innovent will make its breakthrough dual-target, liver fat-reducing weight loss therapy available to obese patients as soon as possible, to contribute towards the weight management and healthy China initiatives,' said chairman Michael Yu Dechao, without giving a time frame.
South China Morning Post
an hour ago
- South China Morning Post
Anwar's big surprise? Malaysians sceptical over ‘tribute' teaser post
A cryptic promise from Prime Minister Anwar Ibrahim has become the latest lightning rod for Malaysia 's restless public, whose patience is wearing thin after months of new taxes, political scandals and economic anxiety. Late on Monday, Anwar posted a stylised silhouette and the words Akan Datang (Coming Soon) across his social media accounts, promising a special gesture of 'extraordinary' appreciation for all Malaysians. The post, which was met with widespread derision, appeared just hours after nearly 1,000 lawyers had marched to the prime minister's office in Putrajaya, protesting alleged government meddling in judicial appointments. Malaysia's digital town square fired back with its trademark blend of wit and scepticism. Comments flooded in, many laced with biting humour about the government's recent expansion of taxes on goods and services , which came into force on July 1. The social media post shared by Anwar late on Monday. The central text reads 'Coming Soon: an extraordinary tribute to the people of Malaysia'. Photo: X/AnwarIbrahim
